Heart Palpitations: When Do You Actually Need an Echocardiogram?

Palpitations account for roughly 16 percent of all primary care visits and are among the most common reasons patients are sent for cardiac evaluation (American Family Physician, 2017). They are also the second most common reason for cardiac ultrasound referral, trailing only cardiac murmurs. Most palpitations are benign — premature atrial or ventricular beats that feel alarming but carry no structural significance. But a clinically meaningful proportion arise from conditions an echocardiogram can find and that change treatment: hypertrophic cardiomyopathy, valvular disease, arrhythmia-induced pump dysfunction, and the structural substrate that drives atrial fibrillation. This article explains when imaging is indicated, what it looks for, and what it changes.

What Exactly Is a Heart Palpitation?

A palpitation is any abnormal awareness of your own heartbeat. That can mean a sense of skipping, fluttering, racing, pounding, or pausing. The sensation comes from a change in heart rate, rhythm, or the force of contraction. It can last one beat or several minutes. Most people who experience palpitations describe them as unsettling even when they are clinically trivial, because the heart is not something we normally feel.

The clinical challenge is that the sensation itself tells you nothing about severity. A premature ventricular contraction — an isolated ectopic beat that fires outside the normal cardiac cycle and then resets — feels like a startling thud followed by a brief pause. It is almost universally benign in a structurally normal heart, but it feels identical to the palpitations someone with hypertrophic cardiomyopathy might experience before a life-threatening arrhythmia. The difference between those two patients is not the symptom. It is what an echocardiogram finds.

The Most Common Causes: Cardiac vs. Non-Cardiac

The cause distribution matters because it determines the workup. Non-cardiac causes are the majority: anxiety, caffeine, dehydration, sleep deprivation, anemia, hyperthyroidism, and medications including stimulants and some antidepressants. These respond to addressing the underlying trigger and rarely require imaging.

Cardiac causes include both arrhythmic and structural origins. The arrhythmic causes — premature atrial contractions (PACs), premature ventricular contractions (PVCs), supraventricular tachycardia (SVT), atrial fibrillation, and ventricular tachycardia — are detected primarily by rhythm monitoring (Holter, event recorder). But structural causes drive a separate and important evaluation pathway:

Hypertrophic Cardiomyopathy (HCM)

HCM affects approximately 1 in 500 adults and is the most common cause of sudden cardiac death in people under 35. It produces palpitations, exertional chest tightness, and near-syncope. The diagnosis is almost exclusively made by echocardiography — which shows asymmetric septal hypertrophy, systolic anterior motion of the mitral valve, and dynamic left ventricular outflow tract obstruction. A resting EKG may be abnormal but is not diagnostic, and many HCM patients have normal tracings.

Mitral Valve Prolapse

MVP affects 2 to 3 percent of the general population and is a known trigger of PVCs and atrial arrhythmias. Echocardiography defines the leaflet anatomy, the degree of regurgitation, and whether the bileaflet or classic morphology is present — the latter carrying a higher arrhythmia risk. MVP with significant regurgitation or redundant leaflets warrants surveillance scanning and, in some cases, surgical referral.

Arrhythmia-Induced Cardiomyopathy

When frequent PVCs or rapid atrial fibrillation persist over months, they can progressively impair left ventricular function even in a previously normal heart — a condition called tachycardia-mediated or arrhythmia-induced cardiomyopathy. It is reversible if caught early. Patients often present with palpitations and subtle fatigue before any formal heart failure symptoms develop. An echocardiogram is the tool that catches the ejection fraction drop before it becomes clinically significant (JACC, 2019).

When Do Palpitations Warrant an Echocardiogram?

The 2019 ACC/AHA/ASE Appropriate Use Criteria for Multimodality Imaging rates echocardiography as appropriate or may-be-appropriate across a range of palpitation presentations (JACC, 2019). The clearest indications are:

Palpitations with exertion or near-syncope

Palpitations that occur during or immediately after physical activity raise the probability of HCM, significant valvular obstruction, or ischemia-triggered arrhythmia substantially. Near-syncope — feeling like you almost blacked out — during a palpitation episode is a red flag that demands echocardiographic evaluation before any further risk stratification. The 2017 AHA/ACC/HRS Ventricular Arrhythmia guidelines explicitly recommend structural imaging in this clinical context (JACC, 2017).

Family history of sudden cardiac death or cardiomyopathy

HCM and arrhythmogenic right ventricular cardiomyopathy (ARVC) are inherited conditions. A first-degree relative with either diagnosis, or any family member who died suddenly and unexpectedly before age 50, makes echocardiography appropriate even if the patient's own symptoms are mild. Cascade screening in families at risk for HCM is specifically recommended in current guidelines.

Newly diagnosed atrial fibrillation

AFib is detected clinically as an irregular heartbeat that patients experience as palpitations, racing heart, or sudden shortness of breath. More than 5 million Americans currently have AFib, with projections of 12.1 million by 2030. Before initiating anticoagulation or rhythm-control therapy, an echocardiogram is standard of care: it evaluates left atrial size (a predictor of AFib recurrence and stroke risk), left atrial appendage anatomy, left ventricular function, and valvular disease that might influence the anticoagulation strategy. Learn more in our article on AFib and echocardiogram evaluation.

Frequent PVCs on monitoring (>10% of beats)

When Holter or event monitoring quantifies PVC burden above roughly 10 to 15 percent of total beats, ejection fraction measurement becomes clinically important. At that burden, tachycardia-induced cardiomyopathy is a real possibility even in previously healthy patients. An echocardiogram confirms whether pump function has already been affected, which determines whether the PVC suppression strategy (medication vs. ablation) needs to be escalated urgently.

What the Echocardiogram Actually Measures

A complete transthoracic echocardiogram for palpitations targets the following parameters:

Left ventricular size and wall thickness. The left ventricle is measured in systole and diastole to determine whether the chamber is dilated (suggesting volume overload or cardiomyopathy) or hypertrophied. Septal wall thickness greater than 15 mm in the absence of a hypertensive explanation raises the probability of HCM and triggers further genetic evaluation.

Ejection fraction. EF is the percentage of blood ejected from the left ventricle with each beat. Normal is 55 to 70 percent. Values below 50 percent indicate systolic dysfunction; values below 40 percent define heart failure with reduced ejection fraction. In a palpitation patient with frequent arrhythmia, a suppressed EF suggests the arrhythmia has already caused myocardial remodeling.

Left atrial size and volume index. Enlarged left atria are the anatomical substrate for atrial fibrillation. Left atrial volume index (LAVI) above 34 mL/m² is associated with increased risk of AFib onset, recurrence after cardioversion, and stroke. This measurement directly informs electrophysiology decisions.

Mitral and aortic valve anatomy. Mitral valve prolapse, mitral regurgitation, and aortic stenosis are all detectable by echocardiography and all cause palpitations via different mechanisms. Quantifying regurgitant volume and valve orifice area determines the clinical urgency of the finding.

Diastolic function and filling pressures. Diastolic dysfunction — impaired relaxation of the left ventricle during filling — raises intracardiac pressure and increases arrhythmia susceptibility. The echocardiogram grades diastolic dysfunction from I to III and estimates filling pressures non-invasively, which helps explain palpitation symptoms in patients without obvious systolic disease.

The Diagnostic Yield: How Often Does Echo Find Something?

A 2023 study in JACC Advances found that echocardiographic abnormalities were present in 53.6 percent of appropriate-indication referrals and 43.3 percent of may-be-appropriate referrals (JACC Advances, 2023). These are not all clinically urgent findings, but they are real structural findings that affect management. Even in the rarely-appropriate category, 20 percent of studies found something abnormal — which is one reason the trend in cardiology has moved toward earlier imaging rather than watchful waiting for patients with any cardiac symptom.

The 2024 AHA Heart Disease and Stroke Statistics reinforce why this matters at scale: cardiovascular disease remains the leading cause of death in the United States, and a large proportion of those deaths are attributable to conditions that are detectable — and treatable — before they become terminal (Circulation, 2024). Palpitations are often the first symptom that brings a patient to clinical attention. Using that opportunity to image the heart — rather than simply reassure — is the higher-value clinical choice when risk factors or clinical features support it.

What Happens If Structural Palpitation Causes Go Undetected?

The consequences depend entirely on the underlying cause. For benign PVCs in a structurally normal heart, missing the diagnosis means continued anxiety and unnecessary downstream testing — frustrating but not dangerous. For structural causes, the trajectory is different:

Undetected HCM in a young patient who continues vigorous athletic activity carries a meaningful risk of sudden cardiac death during exertion. HCM is the leading autopsy finding in young athletes who die on the field. Earlier echocardiographic diagnosis allows activity restriction and, where indicated, implantable defibrillator placement.

Undetected atrial fibrillation carries a fivefold increased stroke risk. Many patients with paroxysmal AFib feel it as intermittent palpitations that self-terminate. Without an arrhythmia diagnosis and echocardiographic workup, they are not started on anticoagulation they may need. Stroke can be the first sign that AFib has been present for months.

Undetected tachycardia-induced cardiomyopathy is one of the most reversible forms of heart failure — but only if caught before the remodeling becomes irreversible. PVC suppression or AFib rate control in the early phase can completely restore ejection fraction. Waiting until symptomatic heart failure develops closes that window. The echocardiogram that finds a borderline EF of 48 percent in an otherwise asymptomatic patient with palpitations is the one that prevents hospitalizations years later.

Frequently Asked Questions